Latest Breaking News On - Early feasibility assessment tool - Page 1 : comparemela.com

Applied BioMath, LLC to Present at PEGS Summit News provided by Share this article CONCORD, Mass., May 4, 2021 /PRNewswire/ Applied BioMath ( www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development today announced their participation at the PEGS Summit occurring virtually May 11-13, 2021. John Burke, PhD, Co-founder, President and CEO of Applied BioMath will present Applied BioMath Assess™ - An Early Feasibility Assessment Tool for Biotherapeutics within the conference program, Advancing Bispecific Antibodies and Combination Therapy to the Clinic on Tuesday, May 11th at 10:40 a.m. ET. In this presentation, Dr. Burke will demonstrate how Applied BioMath s new and interactive software tool systematically investigates the therapeutic characteristics (e.g., format, half-life, affinity, mechanism of action) given target characteristics (e.g., target expression and

Lucia willeJohn burkeKristen zannellaApplied biomathBiomath assessEarly feasibility assessment toolAdvancing bispecific antibodiesCombination therapyMulti specific antibody designMechanistic avidityEngineering bispecific antibodiesலூசியா வில்லேஜான் பர்க்சேர்க்கை சிகிச்சை